157 related articles for article (PubMed ID: 33423968)
1. [Stereotactic body radiotherapy for locally advanced pancreatic cancer: A systemic review].
Tonneau M; Lacornerie T; Mirabel X; Pasquier D
Cancer Radiother; 2021 May; 25(3):283-295. PubMed ID: 33423968
[TBL] [Abstract][Full Text] [Related]
2. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience.
Jumeau R; Delouya G; Roberge D; Donath D; Béliveau-Nadeau D; Campeau MP
Dig Liver Dis; 2018 Apr; 50(4):396-400. PubMed ID: 29326012
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials.
Petrelli F; Comito T; Ghidini A; Torri V; Scorsetti M; Barni S
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):313-322. PubMed ID: 28068239
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1).
Arcelli A; Buwenge M; Macchia G; Bertini F; Guido A; Deodato F; Cilla S; Scotti V; Rosetto ME; Djan I; Parisi S; Mattiucci GC; Cellini F; Fiore M; Bonomo P; Belgioia L; Niespolo RM; Gabriele P; Di Marco M; Simoni N; Mazzarotto R; Morganti AG;
Cancer Med; 2020 Nov; 9(21):7879-7887. PubMed ID: 32910549
[TBL] [Abstract][Full Text] [Related]
6. [Role of radiation therapy in the management of pancreatic cancer].
Huguet F; Rivin Del Campo E; Antoni D; Vendrely V; Hammel P
Cancer Radiother; 2018 Oct; 22(6-7):552-557. PubMed ID: 30100126
[TBL] [Abstract][Full Text] [Related]
7. [Extreme hypofractionated radiation therapy for pancreatic cancer].
Rouffiac M; Ghirardi S; Chevalier C; Bessières I; Peignaux-Casasnovas K; Truc G; Créhange G
Cancer Radiother; 2021 Oct; 25(6-7):692-698. PubMed ID: 34284971
[TBL] [Abstract][Full Text] [Related]
8. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.
de Geus SWL; Eskander MF; Kasumova GG; Ng SC; Kent TS; Mancias JD; Callery MP; Mahadevan A; Tseng JF
Cancer; 2017 Nov; 123(21):4158-4167. PubMed ID: 28708929
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for locally advanced pancreatic cancer.
Jung J; Yoon SM; Park JH; Seo DW; Lee SS; Kim MH; Lee SK; Park DH; Song TJ; Ryoo BY; Chang HM; Kim KP; Yoo C; Jeong JH; Kim SC; Hwang DW; Lee JH; Song KB; Jo YY; Park J; Kim JH
PLoS One; 2019; 14(4):e0214970. PubMed ID: 30978229
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions.
Myrehaug S; Sahgal A; Russo SM; Lo SS; Rosati LM; Mayr NA; Lock M; Small W; Dorth JA; Ellis RJ; Teh BS; Herman JM
Expert Rev Anticancer Ther; 2016 May; 16(5):523-30. PubMed ID: 26999329
[TBL] [Abstract][Full Text] [Related]
12. The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.
Moningi S; Dholakia AS; Raman SP; Blackford A; Cameron JL; Le DT; De Jesus-Acosta AM; Hacker-Prietz A; Rosati LM; Assadi RK; Dipasquale S; Pawlik TM; Zheng L; Weiss MJ; Laheru DA; Wolfgang CL; Herman JM
Ann Surg Oncol; 2015 Jul; 22(7):2352-8. PubMed ID: 25564157
[TBL] [Abstract][Full Text] [Related]
13. Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.
Comito T; Cozzi L; Clerici E; Franzese C; Tozzi A; Iftode C; Navarria P; D'Agostino G; Rimassa L; Carnaghi C; Personeni N; Tronconi MC; De Rose F; Franceschini D; Ascolese AM; Fogliata A; Tomatis S; Santoro A; Zerbi A; Scorsetti M
Technol Cancer Res Treat; 2017 Jun; 16(3):295-301. PubMed ID: 27311310
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design.
Hoffe SE; Aguilera TA; Parikh PJ; Ghaly MM; Herman JM; Caster JM; Kim DW; Costello J; Malafa MP; Moser EC; Kennedy EP; Terry K; Kurman M
Future Oncol; 2024 Mar; 20(8):437-446. PubMed ID: 38264869
[TBL] [Abstract][Full Text] [Related]
16. Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors.
Combs SE
Langenbecks Arch Surg; 2015 Oct; 400(7):749-56. PubMed ID: 26139242
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated.
Chuong MD; Springett GM; Freilich JM; Park CK; Weber JM; Mellon EA; Hodul PJ; Malafa MP; Meredith KL; Hoffe SE; Shridhar R
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):516-22. PubMed ID: 23562768
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy in pancreatic adenocarcinoma.
de la Pinta C
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):14-19. PubMed ID: 36990839
[TBL] [Abstract][Full Text] [Related]
19. Application of stereotactic body radiotherapy in advanced pancreatic cancers in Australia.
Kim L; Nguyen N; Singhal N; Phan VA; Iankov I; Le H
J Med Radiat Sci; 2019 Mar; 66(1):54-61. PubMed ID: 30411540
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
